Search results
Replay wins IND clearance for PRAME T cell cancer therapy
Pharmaceutical Technology via Yahoo Finance· 4 days agoGenome writing company Replay Bio has had its investigational new drug (IND) application cleared by...
Revolutionizing Cancer Treatment: Key to Prolonging CAR T Cell Life Uncovered
SciTechDaily· 5 days agoFOXO1 is required for T cell memory and is linked to longer-lasting clinical outcomes in CAR T cell ...
Valley Children's Receives Historic $15 Million Gift to Create Advanced Cell Therapy Program for...
KTLA-TV Los Angeles· 1 day agoValley Children's Healthcare this week announced a historic donation of $15 million that will significantly enhance the hospital's ability to provide the most advanced bone marrow transplant ...
Newly discovered mechanism of T-cell control can interfere with cancer immunotherapies
Medical Xpress· 1 day agoResearchers from the German Cancer Research Center (DKFZ) and the University Medical Center Mannheim...
Do cutting-edge CAR-T-cell therapies cause cancer? What the data say
Nature· 5 days agoRegulators have identified around 30 cases of cancer linked to this blockbuster treatment. But is...
Cell and gene therapy companies trip at scalability hurdle
Pharmaceutical Technology via Yahoo Finance· 6 days agoSince then, major strides have been made in the cell therapy space. The first chimeric antigen...
New technique improves T cell-based immunotherapies for solid tumors
Medical Xpress· 3 days agoScientists from Scripps Research have enhanced an existing immunotherapy by removing the sugar coating surrounding solid tumors—such as in melanoma, breast, and prostate cancer—so T cells can ...
Valley Children's to offer advanced cancer therapies after $15M gift
Becker’s Hospital Review· 2 days ago-based system said will eliminate the need to refer patients to Los Angeles hospitals for certain treatments. The gift will allow the hospital to stand up a bone marrow transplant and CAR-< ...
IN8bio Doses First Patient in Phase 2 Clinical Trial of INB-400 in Newly Diagnosed Glioblastoma -...
Benzinga· 5 days agoNEW YORK, April 30, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (NASDAQ:INAB), a clinical-stage biopharmaceutical company advancing innovative gamma-delta T cell
CD70 Antibodies CD70 Targeting Therapies Clinical Trials Market Opportunity Insight
Benzinga· 4 days agoDelhi, May 01, 2024 (GLOBE NEWSWIRE) -- Global CD70 Targeting Therapies Market Opportunity & Clinical Trials Insight 2024 Report Highlights: CD70 Targeting Therapies In Clinical Trials: > 20 TherapiesCD 70